| MeSH term | MeSH ID | Detail |
|---|---|---|
| Arthritis, Rheumatoid | D001172 | 3 associated lipids |
| Liver Diseases | D008107 | 31 associated lipids |
| Occupational Diseases | D009784 | 42 associated lipids |
| Kidney Diseases | D007674 | 29 associated lipids |
| Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
| Leukemia P388 | D007941 | 43 associated lipids |
| Chemical and Drug Induced Liver Injury | D056486 | 39 associated lipids |
| Hypertension, Pulmonary | D006976 | 32 associated lipids |
| Myocardial Infarction | D009203 | 21 associated lipids |
| Drug Hypersensitivity | D004342 | 20 associated lipids |
Glucaric acid
Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
Cross Reference
Introduction
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Glucaric acid?
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Glucaric acid
PubChem Associated disorders and diseases
What pathways are associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Glucaric acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Glucaric acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Glucaric acid?
There are no associated biomedical information in the current reference collection.
What genes are associated with Glucaric acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Glucaric acid?
Knock-out
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Glucaric acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Sunder-Plassmann G and Hörl WH | Safety aspects of parenteral iron in patients with end-stage renal disease. | 1997 | Drug Saf | pmid:9352960 |
| Cynke E | [Parenteral iron replacement]. | 1997 | Praxis (Bern 1994) | pmid:9312810 |
| al-Hawas F et al. | Use of i.v. iron saccharate in haemodialysis patients not responding to oral iron and erythropoietin. | 1997 | Nephrol. Dial. Transplant. | pmid:9430909 |
| Sandle LN et al. | Indirect evidence for hepatic induction in patients with cholesterol gallstones. | 1997 | Biochem. Soc. Trans. | pmid:9388642 |
| Miguel JC et al. | Effects of iron salts in sucrose on dental caries and plaque in rats. | 1997 | Arch. Oral Biol. | pmid:9233847 |
| Brunelle FM and Verbeeck RK | Conjugation-deconjugation cycling of diflunisal via beta-glucuronidase catalyzed hydrolysis of its acyl glucuronide in the rat. | 1997 | Life Sci. | pmid:9180355 |
| Sunder-Plassmann G et al. | The dilemma of evaluating iron status in dialysis patients--limitations of available diagnostic procedures. | 1997 | Nephrol. Dial. Transplant. | pmid:9269632 |
| Beanlands RS et al. | Differentiation of myocardial ischemia and necrosis by technetium 99m glucaric acid kinetics. | 1997 Jul-Aug | J Nucl Cardiol | pmid:9278873 |
| Khaw BA et al. | Avidity of technetium 99m glucarate for the necrotic myocardium: in vivo and in vitro assessment. | 1997 Jul-Aug | J Nucl Cardiol | pmid:9278874 |
| Hubbard BK et al. | Evolution of enzymatic activities in the enolase superfamily: characterization of the (D)-glucarate/galactarate catabolic pathway in Escherichia coli. | 1998 | Biochemistry | pmid:9772162 |
| Kuramitsu Y et al. | A new anti-metastatic drug, ND-2001, inhibits lung metastases in rat hepatoma cells by suppressing haptotaxis of tumor cells toward laminin. | 1998 | Anticancer Drugs | pmid:9491797 |
| Nonaka D et al. | Gelatinous bone marrow transformation complicated by self-induced malnutrition. | 1998 | Acta Haematol. | pmid:9792939 |
| Hong SK and Rankin GO | Biotransformation of 2-chloroaniline in the Fischer 344 rat: identification of urinary metabolites. | 1998 | Xenobiotica | pmid:9849645 |
| Sato K and Shiraki M | Saccharated ferric oxide-induced osteomalacia in Japan: iron-induced osteopathy due to nephropathy. | 1998 | Endocr. J. | pmid:9881891 |
| Kuramitsu Y et al. | ND-2001 suppresses lung metastasis of human renal cancer cells in athymic mice. | 1998 | Anticancer Drugs | pmid:9823433 |
| Edelson SB and Cantor DS | Autism: xenobiotic influences. | 1998 Nov-Dec | Toxicol Ind Health | pmid:9891912 |
| Lubberink M et al. | Quantification aspects of patient studies with 52Fe in positron emission tomography. | 1999 | Appl Radiat Isot | pmid:10581681 |
| Braun L et al. | Different induction of gulonolactone oxidase in aromatic hydrocarbon-responsive or -unresponsive mouse strains. | 1999 | FEBS Lett. | pmid:10606751 |
| Mariani G et al. | Detection of acute myocardial infarction by 99mTc-labeled D-glucaric acid imaging in patients with acute chest pain. | 1999 | J. Nucl. Med. | pmid:10565778 |
| Jahn M et al. | The reaction of hyaluronic acid and its monomers, glucuronic acid and N-acetylglucosamine, with reactive oxygen species. | 1999 | Carbohydr. Res. | pmid:10614067 |
| Weisbach V et al. | Oral or intravenous iron as an adjuvant to autologous blood donation in elective surgery: a randomized, controlled study. | 1999 | Transfusion | pmid:10335995 |
| Nakatsugawa S et al. | Inhibitory effect of ND2001 on spontaneous multiple metastasis of NC 65 tumors derived from human renal cancer cells intradermally transplanted into nude mice. | 1999 | Anticancer Drugs | pmid:10211554 |
| Picaud JC et al. | [Iron supplementation in preterm infants treated with erythropoietin]. | 1999 | Arch Pediatr | pmid:10394459 |
| Krafft A et al. | Erythropoietic quality of maternal milk. | 1999 | Lancet | pmid:10475225 |
| Lim PS et al. | Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy. | 1999 | Nephrol. Dial. Transplant. | pmid:10534512 |
| Gasche C et al. | Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin. | 1999 | Digestion | pmid:10343140 |
| Yoshimi N et al. | Inhibition of azoxymethane-induced rat colon carcinogenesis by potassium hydrogen D-glucarate. | 2000 | Int. J. Oncol. | pmid:10601547 |
| Bailie GR et al. | Parenteral iron use in the management of anemia in end-stage renal disease patients. | 2000 | Am. J. Kidney Dis. | pmid:10620537 |
| Descombes E and Fellay G | Improved response to erythropoietin therapy with long-term continuous iron supplementation. | 2000 | Nephron | pmid:10657727 |
| Fujita K et al. | Establishment of Salmonella strain expressing catalytically active human UDP-glucuronosyltransferase 1A1 (UGT1A1). | 2000 | Life Sci. | pmid:10821120 |
| Wiersema AM et al. | Early assessment of skeletal muscle damage after ischaemia-reperfusion injury using Tc-99m-glucarate. | 2000 | Cardiovasc Surg | pmid:10799826 |
| Fujii Y et al. | Inhibition of liver metastases and tumor cell invasion in spontaneous liver metastasis model (LMFS) by sodium D-glucaro-delta-lactam (ND2001). | 2000 | Biomed. Pharmacother. | pmid:10759292 |
| Gulick AM et al. | Evolution of enzymatic activities in the enolase superfamily: crystallographic and mutagenesis studies of the reaction catalyzed by D-glucarate dehydratase from Escherichia coli. | 2000 | Biochemistry | pmid:10769114 |
| Wargovich MJ et al. | Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. | 2000 | Carcinogenesis | pmid:10837003 |
| Parkkinen J et al. | Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration. | 2000 | Nephrol. Dial. Transplant. | pmid:11071973 |
| Kao HH et al. | Clinical characteristic of parenteral iron supplementation in hemodialysis patients receiving erythropoietin therapy. | 2000 | Chang Gung Med J | pmid:11126152 |
| van Iperen CE et al. | Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. | 2000 | Crit. Care Med. | pmid:10966249 |
| Krafft A et al. | Intravenous iron sucrose in two pregnant women with inflammatory bowel disease and severe iron deficiency anemia. | 2000 | Acta Obstet Gynecol Scand | pmid:10949245 |
| Gombotz H et al. | Preoperative treatment with recombinant human erythropoietin or predeposit of autologous blood in women undergoing primary hip replacement. | 2000 | Acta Anaesthesiol Scand | pmid:10903019 |
| Van Wyck DB et al. | Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial. | 2000 | Am. J. Kidney Dis. | pmid:10873877 |
| Monterrubio R et al. | A common regulator for the operons encoding the enzymes involved in D-galactarate, D-glucarate, and D-glycerate utilization in Escherichia coli. | 2000 | J. Bacteriol. | pmid:10762278 |
| Fishbane S and Kowalski EA | The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconate. | 2000 Nov-Dec | Semin Dial | pmid:11130261 |
| Johnson LL et al. | Technetium-99m glucarate uptake in a swine model of limited flow plus increased demand. | 2000 Nov-Dec | J Nucl Cardiol | pmid:11144474 |
| Chandler G et al. | Intravenous iron sucrose: establishing a safe dose. | 2001 | Am. J. Kidney Dis. | pmid:11684551 |
| Charytan C et al. | Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial. | 2001 | Am. J. Kidney Dis. | pmid:11157370 |
| Kosch M and Schaefer RM | [Iron deficiency. When parenteral substitution?]. | 2001 | MMW Fortschr Med | pmid:11247361 |
| Merbouh N et al. | Facile nitroxide-mediated oxidations of D-glucose to D-glucaric acid. | 2001 | Carbohydr. Res. | pmid:11675028 |
| Kaltwasser JP et al. | Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis. | 2001 | J. Rheumatol. | pmid:11708414 |
| Duffy CI | Iron sucrose or ferric gluconate? | 2001 | Am. J. Kidney Dis. | pmid:11728988 |
| Gasche C et al. | Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia. | 2001 | Am. J. Gastroenterol. | pmid:11513178 |